The Food and Drug Administration has approved the first-ever glucagon-like peptide-1 (GLP-1) pill, a milestone that could further expand access to the popular weight-loss treatments. Novo Nordisk announced in a news release on Monday, Dec. 22, that the FDA has cleared its Wegovy weight-los…